Correlation Between Oxford Nanopore and Zentalis Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Oxford Nanopore and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and Zentalis Pharmaceuticals.

Diversification Opportunities for Oxford Nanopore and Zentalis Pharmaceuticals

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Oxford and Zentalis is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and Zentalis Pharmaceuticals go up and down completely randomly.

Pair Corralation between Oxford Nanopore and Zentalis Pharmaceuticals

Assuming the 90 days horizon Oxford Nanopore Technologies is expected to under-perform the Zentalis Pharmaceuticals. In addition to that, Oxford Nanopore is 1.05 times more volatile than Zentalis Pharmaceuticals Llc. It trades about -0.09 of its total potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.05 per unit of volatility. If you would invest  350.00  in Zentalis Pharmaceuticals Llc on October 7, 2024 and sell it today you would lose (26.00) from holding Zentalis Pharmaceuticals Llc or give up 7.43% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Oxford Nanopore Technologies  vs.  Zentalis Pharmaceuticals Llc

 Performance 
       Timeline  
Oxford Nanopore Tech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford Nanopore Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.
Zentalis Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Zentalis Pharmaceuticals Llc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Zentalis Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Oxford Nanopore and Zentalis Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oxford Nanopore and Zentalis Pharmaceuticals

The main advantage of trading using opposite Oxford Nanopore and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.
The idea behind Oxford Nanopore Technologies and Zentalis Pharmaceuticals Llc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume